Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greet Dijkman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Acta Ophthalmologica|November 1, 2018
Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathyFemke M van Haalen, Elon H C van Dijk, Cornelie D Andela, et al.
Frontiers in Endocrinology|March 9, 2018
Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous ChorioretinopathyFemke M van Haalen, Elon H C van Dijk, Olaf M Dekkers, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 6, 2017
Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcomeWing H Chung, Elon H C van Dijk, Danial Mohabati, et al.
Acta Ophthalmologica|May 7, 2016
Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control studyMyrte B Breukink, Danial Mohabati, Elon H C van Dijk, et al.
Acta Ophthalmologica|October 15, 2019
Hair cortisol concentrations in chronic central serous chorioretinopathyFemke M van Haalen, Elon H C van Dijk, Mesut Savas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 1, 2018
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapyDanial Mohabati, Elon Hc van Dijk, Thomas J van Rijssen, et al.
American Journal of Ophthalmology|July 2, 2021
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled TrialThomas J van Rijssen, Elon H C van Dijk, Roula Tsonaka, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Acta Ophthalmologica|November 1, 2018
Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathyFemke M van Haalen, Elon H C van Dijk, Cornelie D Andela, et al.
Frontiers in Endocrinology|March 9, 2018
Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous ChorioretinopathyFemke M van Haalen, Elon H C van Dijk, Olaf M Dekkers, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 6, 2017
Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcomeWing H Chung, Elon H C van Dijk, Danial Mohabati, et al.
Acta Ophthalmologica|May 7, 2016
Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control studyMyrte B Breukink, Danial Mohabati, Elon H C van Dijk, et al.
Acta Ophthalmologica|October 15, 2019
Hair cortisol concentrations in chronic central serous chorioretinopathyFemke M van Haalen, Elon H C van Dijk, Mesut Savas, et al.
Clinical Ophthalmology (Auckland, N.Z.)|December 1, 2018
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapyDanial Mohabati, Elon Hc van Dijk, Thomas J van Rijssen, et al.
American Journal of Ophthalmology|July 2, 2021
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled TrialThomas J van Rijssen, Elon H C van Dijk, Roula Tsonaka, et al.
Retina (Philadelphia, Pa.)|December 1, 2017
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHYElon H C van Dijk, Rosa L Schellevis, Myrte B Breukink, et al.
American Journal of Ophthalmology|April 15, 2020
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE TrialThomas J van Rijssen, Elon H C van Dijk, Paula Scholz, et al.
American Journal of Ophthalmology|November 14, 2020
Reply to Comment on: Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous ChorioretinopathyThomas J van Rijssen, Elon H C van Dijk, Greet Dijkman, et al.
Pageof 3